$CTV
Innovid Corp. Stock $ctv

$ctv Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000183537822000032 Filed on March 18, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$25.97M	$90.29M	$23.03M
YoY Change	12.75%	31.24%
Cost Of Revenue	$5.367M	$17.79M	$3.820M
YoY Change	40.5%	43.83%
Gross Profit	$20.60M	$72.51M	$19.21M
YoY Change	7.24%	28.47%
Gross Profit Margin	79.33%	80.3%	83.41%
Selling, General & Admin	$19.62M	$53.74M	$8.790M
YoY Change	123.15%	45.11%
% of Gross Profit	95.22%	74.11%	45.76%
Research & Development	$7.687M	$24.62M	$4.610M
YoY Change	66.75%	34.66%
% of Gross Profit	37.32%	33.95%	24.0%
Depreciation & Amortization	$174.0K	$661.0K	$250.0K
YoY Change	-30.4%	-9.45%
% of Gross Profit	0.84%	0.91%	1.3%
Operating Expenses	$27.30M	$78.36M	$13.40M
YoY Change	103.75%	41.65%
Operating Profit	-$6.702M	-$5.849M	$5.810M
YoY Change	-215.35%	-621.3%
Interest Expense	-$508.0K	-$4.386M	-$210.0K
YoY Change	141.9%	497.55%
% of Operating Profit			-3.61%
Other Income/Expense, Net
YoY Change
Pretax Income	-$7.210M	-$10.24M	$5.610M
YoY Change	-228.52%	-2737.89%
Income Tax	$408.0K	$1.237M	$300.0K
% Of Pretax Income			5.35%
Net Earnings	-$7.618M	-$11.47M	$1.880M
YoY Change	-505.21%	1312.81%
Net Earnings / Revenue	-29.34%	-12.71%	8.16%
Basic Earnings Per Share		-$3.31
Diluted Earnings Per Share	-$63.89K	-$3.31	$0.02
COMMON SHARES
Basic Shares Outstanding		26.75M shares
Diluted Shares Outstanding		26.75M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$156.7M	$156.7M
YoY Change		901.57%
Cash & Equivalents	$156.7M	$156.7M	$15.65M
Short-Term Investments
Other Short-Term Assets	$503.0K	$3.131M	$197.0K
YoY Change	155.33%	166.7%
Inventory
Prepaid Expenses	$2.333M		$862.0K
Receivables	$35.42M	$35.42M	$34.80M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$195.2M	$195.2M	$51.62M
YoY Change	278.22%	278.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.840M	$4.840M	$2.325M
YoY Change	108.17%	108.17%
Goodwill	$4.555M		$4.555M
YoY Change	0.0%
Intangibles	$0.00		$33.00K
YoY Change	-100.0%
Long-Term Investments	$310.0K	$310.0K
YoY Change		-10.92%
Other Assets	$116.0K	$578.0K	$127.0K
YoY Change	-8.66%	0.7%
Total Long-Term Assets	$10.28M	$10.28M	$7.835M
YoY Change	31.24%	31.24%
TOTAL ASSETS
Total Short-Term Assets	$195.2M	$195.2M	$51.62M
Total Long-Term Assets	$10.28M	$10.28M	$7.835M
Total Assets	$205.5M	$205.5M	$59.46M
YoY Change	245.68%	245.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.026M	$5.026M	$1.854M
YoY Change	171.09%	171.09%
Accrued Expenses	$3.082M	$10.79M	$1.155M
YoY Change	166.84%	42.23%
Deferred Revenue	$101.0K		$118.0K
YoY Change	-14.41%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.000M	$6.000M	$1.527M
YoY Change	292.93%	292.93%
Total Short-Term Liabilities	$21.85M	$21.85M	$11.04M
YoY Change	97.88%	97.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$7.506M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$3.455M	$22.43M	$3.144M
YoY Change	9.89%	515.62%
Total Long-Term Liabilities	$22.43M	$22.43M	$11.15M
YoY Change	101.16%	101.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.85M	$21.85M	$11.04M
Total Long-Term Liabilities	$22.43M	$22.43M	$11.15M
Total Liabilities	$44.28M	$44.28M	$22.19M
YoY Change	99.53%	99.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$132.5M		-$48.11M
YoY Change	175.34%
Common Stock	$12.00K		$2.000K
YoY Change	500.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00		$1.629M
YoY Change	-100.0%
Treasury Stock Shares	0.000 shares		1.914M shares
Shareholders Equity	$161.3M	$161.3M	-$49.73M
YoY Change
Total Liabilities & Shareholders Equity	$205.5M	$205.5M	$59.46M
YoY Change	245.68%	245.68%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$7.618M	-$11.47M	$1.880M
YoY Change	-505.21%	1312.81%
Depreciation, Depletion And Amortization	$174.0K	$661.0K	$250.0K
YoY Change	-30.4%	-9.45%
Cash From Operating Activities	-$5.467M	-$2.421M	-$1.680M
YoY Change	225.42%	-41.79%
INVESTING ACTIVITIES
Capital Expenditures	-$1.716M	$549.0K	$230.0K
YoY Change	-846.09%	-46.7%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$27.00K	-$544.0K	$30.00K
YoY Change	-190.0%	-763.41%
Cash From Investing Activities	-$1.743M	-$3.687M	-$200.0K
YoY Change	771.5%	288.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$3.033M
YoY Change		-53.37%
Cash From Financing Activities	149.5M	$147.2M	-560.0K
YoY Change	-26787.68%	1534.9%
NET CHANGE
Cash From Operating Activities	-5.467M	-$2.421M	-1.680M
Cash From Investing Activities	-1.743M	-$3.687M	-200.0K
Cash From Financing Activities	149.5M	$147.2M	-560.0K
Net Change In Cash	142.2M	$141.1M	-2.440M
YoY Change	-5929.55%	3521.72%
FREE CASH FLOW
Cash From Operating Activities	-$5.467M	-$2.421M	-$1.680M
Capital Expenditures	-$1.716M	$549.0K	$230.0K
Free Cash Flow	-$3.751M	-$2.970M	-$1.910M
YoY Change	96.39%	-42.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001835378
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3769599
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 Irving Place,
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-40048
CY2021	dei	Entity Registrant Name EntityRegistrantName	Innovid Corp.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10003
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Local Phone Number LocalPhoneNumber	966-7555
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	331000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	131718858	shares
CY2021	dei	Auditor Firm AuditorFirmId	1281
CY2021	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2021	dei	Auditor Name AuditorName	KOST FORER GABBAY & KASIERER
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156696000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15645000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	81000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	121000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35422000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34804000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3131000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1174000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	195249000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	51623000	USD
CY2021Q4	iacb	Long Term Other Deposit LongTermOtherDeposit	310000	USD
CY2020Q4	iacb	Long Term Other Deposit LongTermOtherDeposit	348000	USD
CY2021Q4	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	462000	USD
CY2020Q4	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	447000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4840000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2325000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	4555000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	4555000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	127000	USD
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10283000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7835000	USD
CY2021Q4	us-gaap	Assets Assets	205532000	USD
CY2020Q4	us-gaap	Assets Assets	59458000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5026000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1854000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7742000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6506000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3082000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1155000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1527000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21850000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11042000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7506000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3455000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3144000	USD
CY2021Q4	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	18972000	USD
CY2020Q4	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	499000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22427000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11149000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	44277000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	22191000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	500000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	74236884	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	73690340	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	86997000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100634071	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119017380	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18189937	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119017380	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16275609	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1914328	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1629000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293719000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132476000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48113000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-49730000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	205532000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59458000	USD
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90291000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68801000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56338000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	17785000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	12365000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14766000	USD
CY2020	us-gaap	Gross Profit GrossProfit	56436000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	10583000	USD
CY2021	us-gaap	Gross Profit GrossProfit	72506000	USD
CY2019	us-gaap	Gross Profit GrossProfit	45755000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24619000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18283000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	33056000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28810000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29409000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20680000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8221000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7625000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	78355000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	55314000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	51800000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-5849000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	1122000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-6045000	USD
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	4386000	USD
CY2020	us-gaap	Interest And Debt Expense InterestAndDebtExpense	734000	USD
CY2019	us-gaap	Interest And Debt Expense InterestAndDebtExpense	387000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10235000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	388000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6432000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1237000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1200000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	902000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11472000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-812000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7334000	USD
CY2021	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	77063000	USD
CY2020	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	7297000	USD
CY2019	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	2007000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-88535000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-88535000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8109000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8109000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9341000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9341000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.31
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26745020	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26745020	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16028560	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16028560	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15886958	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15886958	shares
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	60813980	shares
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	48001000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-33923000	USD
CY2019	iacb	Temporary Equity Issuance Of Preferred Stocks Net Of Issuance Cost Shares TemporaryEquityIssuanceOfPreferredStocksNetOfIssuanceCostShares	12876360	shares
CY2019	iacb	Temporary Equity Issuance Of Preferred Stocks Net Of Issuance Cost TemporaryEquityIssuanceOfPreferredStocksNetOfIssuanceCost	29692000	USD
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2007000	USD
CY2019	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	2007000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	378000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	99000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7334000	USD
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	79700000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-42787000	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	7297000	USD
CY2020	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	7297000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	-504000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	584000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	78000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-812000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	86997000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-49730000	USD
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	77063000	USD
CY2021	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	77063000	USD
CY2021	iacb	Temporary Equity Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Shares TemporaryEquityConversionOfRedeemableConvertiblePreferredStockIntoCommonStockShares	73690340	shares
CY2021	iacb	Temporary Equity Conversion Of Redeemable Convertible Preferred Stock Into Common Stock TemporaryEquityConversionOfRedeemableConvertiblePreferredStockIntoCommonStock	-164060000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	164060000	USD
CY2021	iacb	Reverse Recapitalization Value Net ReverseRecapitalizationValueNet	126026000	USD
CY2021	iacb	Stock Issued During Period Value Conversion Of Warrants StockIssuedDuringPeriodValueConversionOfWarrants	5080000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3273000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1081000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11472000	USD
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11472000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-812000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7334000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	661000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	730000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	431000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3273000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	584000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	378000	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-127000	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	USD
CY2019	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware		USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	24000	USD
CY2021	iacb	Founders Notes Forgiven FoundersNotesForgiven	459000	USD
CY2020	iacb	Transaction Costs Allocated To Warrants TransactionCostsAllocatedToWarrants	0	USD
CY2019	iacb	Transaction Costs Allocated To Warrants TransactionCostsAllocatedToWarrants	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	762000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	86000	USD
CY2020	iacb	Founders Notes Forgiven FoundersNotesForgiven	0	USD
CY2019	iacb	Founders Notes Forgiven FoundersNotesForgiven	0	USD
CY2021	iacb	Transaction Costs Allocated To Warrants TransactionCostsAllocatedToWarrants	2750000	USD
CY2021	iacb	Noncash Interest Expense NoncashInterestExpense	0	USD
CY2020	iacb	Noncash Interest Expense NoncashInterestExpense	22000	USD
CY2019	iacb	Noncash Interest Expense NoncashInterestExpense	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	618000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8372000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5174000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1823000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-78000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	546000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1500000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-545000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	721000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1236000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1914000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1579000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	851000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2029000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	939000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2421000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4159000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8982000	USD
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2594000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	549000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1030000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1657000	USD
CY2021	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	459000	USD
CY2020	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	USD
CY2019	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4232000	USD
CY2021	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	-85000	USD
CY2020	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	76000	USD
CY2019	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	-333000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3687000	USD
CY2021	iacb	Proceeds From Reverse Recapitalization Net ProceedsFromReverseRecapitalizationNet	149252000	USD
CY2020	iacb	Proceeds From Reverse Recapitalization Net ProceedsFromReverseRecapitalizationNet	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-948000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6222000	USD
CY2019	iacb	Proceeds From Reverse Recapitalization Net ProceedsFromReverseRecapitalizationNet	0	USD
CY2021	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	USD
CY2020	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	504000	USD
CY2019	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	29692000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15516000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3033000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6504000	USD
CY2019	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1081000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	USD
CY2021	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	126000	USD
CY2020	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	592000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	78000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	99000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	147174000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9002000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23791000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	141066000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3895000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8587000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16092000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12197000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3610000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12197000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	259000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	272000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157158000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16092000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	535000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	421000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	208000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	328000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	164060000	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	iacb	Conversion Of Legacy Innovid Warrants ConversionOfLegacyInnovidWarrants	5080000	USD
CY2020	iacb	Conversion Of Legacy Innovid Warrants ConversionOfLegacyInnovidWarrants	0	USD
CY2019	iacb	Conversion Of Legacy Innovid Warrants ConversionOfLegacyInnovidWarrants	0	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
CY2020	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	7297000	USD
CY2020	iacb	Accrued Transaction Cost Not Yet Paid AccruedTransactionCostNotYetPaid	0	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	718000	USD
CY2021	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	77063000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	126000	USD
CY2019	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	2007000	USD
CY2021	iacb	Accrued Transaction Cost Not Yet Paid AccruedTransactionCostNotYetPaid	3185000	USD
CY2019	iacb	Accrued Transaction Cost Not Yet Paid AccruedTransactionCostNotYetPaid	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156696000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15645000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11641000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	462000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	447000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	416000	USD
CY2021Q4	iacb	Restricted Cash In Prepaid Expenses And Other Current Assets RestrictedCashInPrepaidExpensesAndOtherCurrentAssets	0	USD
CY2020Q4	iacb	Restricted Cash In Prepaid Expenses And Other Current Assets RestrictedCashInPrepaidExpensesAndOtherCurrentAssets	0	USD
CY2019Q4	iacb	Restricted Cash In Prepaid Expenses And Other Current Assets RestrictedCashInPrepaidExpensesAndOtherCurrentAssets	140000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157158000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16092000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12197000	USD
CY2021Q4	iacb	Temporary Equity Secondary Sale Amount TemporaryEquitySecondarySaleAmount	68855000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of estimates:The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The COVID-19 pandemic has created, and may continue to create significant uncertainty in macroeconomic conditions, and the extent of its impact on the Company’s operational and financial performance will depend on certain developments, including the duration and spread of the outbreak and the impact on the Company’s customers. Based on public reporting and the Company’s observations, some advertisers in certain industries, such as the automotive industry, decreased and may continue to decrease their short-term advertising spending in light of supply chain disruptions and/or labor shortage they may be experiencing. This in turn could negatively impact the Company’s revenues from such advertisers.The Company has considered the impact of COVID-19 on its estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the period ended December 31, 2021 and 2020. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	579000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingUnit
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingUnit
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	755000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	600000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of credit risks:<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in America and Israel. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net are mainly derived from sales to customers located in the APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div>The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
CY2021	iacb	Revenue From Contract With Customer Payment Term RevenueFromContractWithCustomerPaymentTerm	P60D
CY2021	iacb	Revenue Recognition Advertisement Serving Percentage RevenueRecognitionAdvertisementServingPercentage	0.936
CY2020	iacb	Revenue Recognition Advertisement Serving Percentage RevenueRecognitionAdvertisementServingPercentage	0.965
CY2019	iacb	Revenue Recognition Advertisement Serving Percentage RevenueRecognitionAdvertisementServingPercentage	0.969
CY2021	iacb	Revenue Recognition Creative Serving Percentage RevenueRecognitionCreativeServingPercentage	0.048
CY2020	iacb	Revenue Recognition Creative Serving Percentage RevenueRecognitionCreativeServingPercentage	0.028
CY2019	iacb	Revenue Recognition Creative Serving Percentage RevenueRecognitionCreativeServingPercentage	0.025
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2333000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	862000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	142000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	30000	USD
CY2021Q4	iacb	Government Contract Receivable Current GovernmentContractReceivableCurrent	153000	USD
CY2020Q4	iacb	Government Contract Receivable Current GovernmentContractReceivableCurrent	85000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	503000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	197000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3131000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1174000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7198000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4055000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2358000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1730000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4840000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2325000	USD
CY2021	us-gaap	Depreciation Depreciation	628000	USD
CY2020	us-gaap	Depreciation Depreciation	531000	USD
CY2019	us-gaap	Depreciation Depreciation	332000	USD
CY2021	iacb	Accrued Transaction Cost Not Yet Paid AccruedTransactionCostNotYetPaid	3185000	USD
CY2021Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	34345000	USD
CY2021	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	6199000	USD
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2021	iacb	Temporary Equity Secondary Sale Amount TemporaryEquitySecondarySaleAmount	68855000	USD
CY2021	iacb	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	31160000	USD
CY2021	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	6199000	USD
CY2021	iacb	Net Proceeds From The Transaction Before Secondary Sale Amount NetProceedsFromTheTransactionBeforeSecondarySaleAmount	149252000	USD
CY2021	iacb	Accrued Direct Transaction Cost AccruedDirectTransactionCost	3185000	USD
CY2021	iacb	Warrant Assumed As Part Of Transaction WarrantAssumedAsPartOfTransaction	22791000	USD
CY2021	iacb	Payments Of Reverse Recapitalization Transaction Costs Warrants PaymentsOfReverseRecapitalizationTransactionCostsWarrants	2750000	USD
CY2021	iacb	Reverse Recapitalization Net Of Transaction Costs Before Secondary Sale Amount ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount	126026000	USD
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4853000	USD
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1	shares
CY2021Q4	iacb	Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination	P30D
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2485000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	317000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	39000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	126000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	101000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	118000	USD
CY2021Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	420000	USD
CY2020Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	391000	USD
CY2021Q4	iacb	Acquisition Liability Current AcquisitionLiabilityCurrent	0	USD
CY2020Q4	iacb	Acquisition Liability Current AcquisitionLiabilityCurrent	126000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	73690340	shares
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	77000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3082000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1155000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	996000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1445000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	2459000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1699000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3455000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M28D
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3144000	USD
CY2020Q3	iacb	Warrants Extended Exercisable Period WarrantsExtendedExercisablePeriod	P18M
CY2010Q2	iacb	Warrants Fair Market Value Shares WarrantsFairMarketValueShares	1	shares
CY2021	iacb	Fractional Shares Issued Upon Exercise FractionalSharesIssuedUponExercise	0	shares
CY2021	iacb	Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination	P30D
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	3819000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2072000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2215000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2474000	USD
CY2021Q4	iacb	Bank Guarantees In Connection With Office Lease Agreement BankGuaranteesInConnectionWithOfficeLeaseAgreement	231000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	73690340	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	500000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	74236884	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	73690340	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	86997000	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	87131986	USD
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	73690340	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	73690340	shares
CY2021	us-gaap	Dividends Dividends	0	USD
CY2021Q4	iacb	Temporary Equity Conversion Ipo Threshold TemporaryEquityConversionIPOThreshold	60000	USD
CY2021Q4	iacb	Temporary Equity Equity Value Threshold TemporaryEquityEquityValueThreshold	500000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100634071	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119017380	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18189937	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119017380	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16275609	shares
CY2019Q1	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0165
CY2021Q4	iacb	Temporary Equity Options Outstanding Reserved For Future Issuance TemporaryEquityOptionsOutstandingReservedForFutureIssuance	11302275	shares
CY2020Q4	iacb	Temporary Equity Options Outstanding Reserved For Future Issuance TemporaryEquityOptionsOutstandingReservedForFutureIssuance	13204528	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	208704	shares
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1548562	shares
CY2021Q4	iacb	Temporary Equity Options Available For Future Grant TemporaryEquityOptionsAvailableForFutureGrant	11510979	shares
CY2020Q4	iacb	Temporary Equity Options Available For Future Grant TemporaryEquityOptionsAvailableForFutureGrant	14753090	shares
CY2012Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1914328	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1629000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.31
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.53
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.35
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4128000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.65
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.79
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0191
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M9D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M9D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0106
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0111
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0062
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0082
CY2021	iacb	Share Based Compensation Arrangement By Share Based Payment Award Remaining Expiration Period ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingExpirationPeriod	P24M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P1Y
CY2021	iacb	Share Based Compensation Arrangement By Share Based Payment Award Founders Terminated Or Leave Period ShareBasedCompensationArrangementByShareBasedPaymentAwardFoundersTerminatedOrLeavePeriod	P12M
CY2021	iacb	Share Based Compensation Arrangement By Share Based Payment Award Termination Of Employment Provision Award Vesting Rights Percentage ShareBasedCompensationArrangementByShareBasedPaymentAwardTerminationOfEmploymentProvisionAwardVestingRightsPercentage	0.50
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	623000	USD
CY2021Q2	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1199000	USD
CY2021Q2	iacb	Share Based Compensation Arrangement By Share Based Payment Award Value Of Options Fully Vested For Notes Receivable Exercises ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfOptionsFullyVestedForNotesReceivableExercises	740000	USD
CY2021	iacb	Remainder Amount Of Other Purposes And Recognized Bonus Related Expense Upon Forgiveness RemainderAmountOfOtherPurposesAndRecognizedBonusRelatedExpenseUponForgiveness	459000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11098000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1241000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1237000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	257000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10235000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6689000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	863000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-853000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	388000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6432000	USD
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-8000	USD
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	96000	USD
CY2019	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	25000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1245000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1104000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	877000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1200000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	902000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1241000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6689000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	863000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11098000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-853000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	257000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10235000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	388000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6432000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2149000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	81000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1351000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-14000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-155000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-52000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-359000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	207000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-464000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	81000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	40000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	114000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-118000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	100000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	98000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Amount EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount	308000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Amount EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount	0	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Amount EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount	261000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	19000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	17000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1237000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1493000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	159000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1661000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	338000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	469000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	301000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Change In Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsAmount	881000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Change In Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsAmount	956000	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Change In Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsAmount	880000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Foreign Currency Adjustment Amount EffectiveIncomeTaxRateReconciliationForeignCurrencyAdjustmentAmount	-22000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Foreign Currency Adjustment Amount EffectiveIncomeTaxRateReconciliationForeignCurrencyAdjustmentAmount	187000	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Foreign Currency Adjustment Amount EffectiveIncomeTaxRateReconciliationForeignCurrencyAdjustmentAmount	22000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Withholding Tax Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxAmount	266000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Withholding Tax Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxAmount	113000	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Withholding Tax Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxAmount	73000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Nondeductible Expense Deduction Limitation To Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDeductionLimitationToCompensationAmount	538000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Nondeductible Expense Deduction Limitation To Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDeductionLimitationToCompensationAmount	0	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Nondeductible Expense Deduction Limitation To Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDeductionLimitationToCompensationAmount	0	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Warrants EffectiveIncomeTaxRateReconciliationWarrants	160000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Warrants EffectiveIncomeTaxRateReconciliationWarrants	-5000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	578000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	0	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	0	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Warrants EffectiveIncomeTaxRateReconciliationWarrants	5000	USD
CY2021	iacb	Effective Income Tax Rate Reconciliation Tax Inflation Adjustment EffectiveIncomeTaxRateReconciliationTaxInflationAdjustment	185000	USD
CY2020	iacb	Effective Income Tax Rate Reconciliation Tax Inflation Adjustment EffectiveIncomeTaxRateReconciliationTaxInflationAdjustment	0	USD
CY2019	iacb	Effective Income Tax Rate Reconciliation Tax Inflation Adjustment EffectiveIncomeTaxRateReconciliationTaxInflationAdjustment	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	111000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-33000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-61000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-364000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1200000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	902000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.12
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	127000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	3.09
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.14
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	187000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	164000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10201000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9131000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1128000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	891000	USD
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	25000	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	597000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	716000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	106000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	180000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	176000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12445000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11184000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56338000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4840000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12445000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11184000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	8720000	USD
CY2020Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	7594000	USD
CY2021Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	1224000	USD
CY2020Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	873000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2373000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3162000	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	74198000	USD
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	64255000	USD
CY2021Q4	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	82000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2373000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1438000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	508000	USD
CY2021Q4	iacb	Related Party Transaction Research And Development Expenses RelatedPartyTransactionResearchAndDevelopmentExpenses	2000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	410000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	691000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	935000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3162000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2373000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3162000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2373000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	136000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	49000	USD
CY2021Q2	iacb	Share Based Compensation Arrangement By Share Based Payment Award Value Of Options Fully Vested For Notes Receivable Exercises ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfOptionsFullyVestedForNotesReceivableExercises	740000	USD
CY2021Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	6100000	USD
CY2021Q4	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	4130000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	operatingSegment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90291000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68801000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26745020	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16028560	shares
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2325000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16028560	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11472000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-812000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7334000	USD
CY2021	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	77063000	USD
CY2020	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	7297000	USD
CY2019	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	2007000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-88535000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-88535000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8109000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8109000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9341000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9341000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26745020	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15886958	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15886958	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.31
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.31
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337

Files In Submission

Name	View Source	Status
0001835378-22-000032-index-headers.html	Edgar Link	pending
0001835378-22-000032-index.html	Edgar Link	pending
0001835378-22-000032.txt	Edgar Link	pending
0001835378-22-000032-xbrl.zip	Edgar Link	pending
a211listofsubsidiariesofth.htm	Edgar Link	pending
a231consentofernstyoungglo.htm	Edgar Link	pending
a311certificationofceosect.htm	Edgar Link	pending
a312certificationofcfosect.htm	Edgar Link	pending
a321certificationofceo18us.htm	Edgar Link	pending
a322certificationofcfo18us.htm	Edgar Link	pending
a44descriptionofsecurities.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
iacb-20211231.htm	Edgar Link	pending
iacb-20211231.xsd	Edgar Link	pending
iacb-20211231_cal.xml	Edgar Link	unprocessable
iacb-20211231_def.xml	Edgar Link	unprocessable
iacb-20211231_g1.jpg	Edgar Link	pending
iacb-20211231_htm.xml	Edgar Link	completed
iacb-20211231_lab.xml	Edgar Link	unprocessable
iacb-20211231_pre.xml	Edgar Link	unprocessable
image.jpg	Edgar Link	pending
innovidcorp-dexcertifica.htm	Edgar Link	pending
innovidcorp-dexcertifica001.jpg	Edgar Link	pending
innovidcorp-dexcertifica002.jpg	Edgar Link	pending
innovidcorp-dexcertifica003.jpg	Edgar Link	pending
innovidcorp-dexcertifica004.jpg	Edgar Link	pending
innovidcorp-dexcertifica005.jpg	Edgar Link	pending
innovidcorp-dexcertifica006.jpg	Edgar Link	pending
innovidcorp-dexcertifica007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTV
Innovid Corp. Stock $ctv

2021 Q4 Form 10-K Financial Statement

#000183537822000032 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV Innovid Corp. Stock $ctv

2021 Q4 Form 10-K Financial Statement

#000183537822000032 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV
Innovid Corp. Stock $ctv